# F-18 Rhodamine 6G PET Imaging for Myocardial Blood Flow

> **NCT04528758** · EARLY_PHASE1 · SUSPENDED · sponsor: **Washington University School of Medicine** · enrollment: 15 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Rhodamine 6G

## Key facts

- **NCT ID:** NCT04528758
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2018-10-16
- **Primary completion:** 2024-06
- **Final completion:** 2024-12
- **Target enrollment:** 15 (ESTIMATED)
- **Why stopped:** re-evaluation of radiotracer
- **Last updated:** 2022-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04528758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04528758, "F-18 Rhodamine 6G PET Imaging for Myocardial Blood Flow". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04528758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*